放射治疗和癌症免疫治疗中的表观遗传修饰
Shih-Kai Hung1,2,3, Moon-Sing Lee1,3, Wen-Yen Chiou1,3
1Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.
Tzu chi medical journal
|October 18, 2024
概括
将放射疗法 (RT) 与免疫疗法 (IT) 结合起来,称为放射IT (RIT),对癌症治疗有希望. 先进的技术和表观遗传生物标志物是克服RIT挑战和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 放射治疗 (RT) 是癌症管理的基石.
- 结合RT与免疫疗法 (IT),称为无线电IT (RIT),是新兴和积极的研究领域.
- 在优化RIT方面存在重大挑战,包括先进的辐射技术,预测生物标志物和与其他疗法集成.
研究的目的:
- 审查现代瘤学RIT中新出现的挑战和进展.
- 在RIT中评估临床实践,实验室研究和多模式治疗.
- 突出先进的辐射技术和表观遗传修饰作为预测/预后生物标志物和治疗点的潜力.
主要方法:
- 在RIT中审查当前的临床实践和实验室研究.
- 评估先进的辐射技术,如立体射线手术/放射治疗,立体体射线治疗和FLASH-RT.
- 对新型免疫疗法药物和组合疗法的分析,包括向和热疗法.
- 对表观遗传修饰的研究,特别是基于6(m) A的药物,作为生物标志物和治疗点.
主要成果:
- 先进的辐射技术正在与IT一起用于精确的瘤向.
- 新的IT药物和组合疗法 (向,热) 正在调查中.
- 表观遗传修饰,如基于6(m) A的药物,显示出增强RIT疗效的潜力.
- 临床适用的生物标志物正在与先进的辐射技术一起开发.
结论:
- 在癌症管理方面,RIT提出了重大挑战,但也提供了巨大的潜力.
- 先进的辐射技术和表观遗传修饰对于优化RIT至关重要.
- 需要进一步的前性随机试验来验证新生物标志物和治疗策略在RIT中的作用.
更多相关视频
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
769
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
相关概念视频
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
